Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Harpoon Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 46 | 44 | −2 |
| Shares | 17.4M | 16.9M | −544.1K (−3.1%) |
| Value | $12.9M | $12.0M | −$959.7K (−7.4%) |
New holders (4)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 16,734 | $11.9K | 0.00% |
| HRT Financial LP | 10,894 | $7.00K | 0.00% |
| Citadel Advisors LLC | 6,373 | $4.53K | 0.00% |
| Group One Trading, L.P. | 3,848 | $2.73K | 0.00% |
Sold out (6)
Institutions that held Harpoon Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Bailard, Inc. | 63,200 | $47.0K |
| Susquehanna International Group, LLP | 53,949 | $40.1K |
| Prudential Financial Inc | 43,400 | $32.3K |
| CM Wealth Advisors LLC | 50,354 | $29.0K |
| Zacks Investment Management | 30,042 | $22.4K |
| Investors Research Corp | 60 | $45 |